Raras
Buscar doenças, sintomas, genes...
Hipertensão pulmonar tromboembólica crônica
ORPHA:70591CID-10 · I26.0CID-11 · BB01.3OMIM 612862DOENÇA RARA

A Hipertensão Pulmonar Tromboembólica Crônica (HPTEC) acontece quando coágulos de sangue antigos e organizados (que parecem cicatrizes) permanecem nas artérias dos pulmões, entupindo-as. Isso faz com que os vasos sanguíneos dos pulmões fiquem mais estreitos e rígidos, aumentando a dificuldade para o sangue passar (um problema chamado de resistência vascular pulmonar, RVP). Essa situação leva a um aumento da pressão nos pulmões (hipertensão pulmonar, HP) e, com o tempo, à perda progressiva da força do lado direito do coração (insuficiência cardíaca direita).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A Hipertensão Pulmonar Tromboembólica Crônica (HPTEC) acontece quando coágulos de sangue antigos e organizados (que parecem cicatrizes) permanecem nas artérias dos pulmões, entupindo-as. Isso faz com que os vasos sanguíneos dos pulmões fiquem mais estreitos e rígidos, aumentando a dificuldade para o sangue passar (um problema chamado de resistência vascular pulmonar, RVP). Essa situação leva a um aumento da pressão nos pulmões (hipertensão pulmonar, HP) e, com o tempo, à perda progressiva da força do lado direito do coração (insuficiência cardíaca direita).

Pesquisas ativas
20 ensaios
135 total registrados no ClinicalTrials.gov
Publicações científicas
3.747 artigos
Último publicado: 2026 Mar 20

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Adolescent
+ adult, elderly
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: I26.0
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

❤️
Coração
7 sintomas
🫁
Pulmão
4 sintomas
🩸
Sangue
3 sintomas
🛡️
Imunológico
1 sintomas
😀
Face
1 sintomas
🧠
Neurológico
1 sintomas

+ 17 sintomas em outras categorias

Características mais comuns

90%prev.
Hipertensão arterial pulmonar
Muito frequente (99-80%)
90%prev.
Aumento da resistência vascular pulmonar
Muito frequente (99-80%)
90%prev.
Insuficiência cardíaca congestiva
Muito frequente (99-80%)
55%prev.
Trombose venosa profunda
Frequente (79-30%)
55%prev.
Palpitações
Frequente (79-30%)
55%prev.
Dispneia de esforço
Frequente (79-30%)
37sintomas
Muito frequente (3)
Frequente (7)
Ocasional (23)
Muito raro (4)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 37 características clínicas mais associadas, ordenadas por frequência.

Hipertensão arterial pulmonarPulmonary arterial hypertension
Muito frequente (99-80%)90%
Aumento da resistência vascular pulmonarIncreased pulmonary vascular resistance
Muito frequente (99-80%)90%
Insuficiência cardíaca congestivaCongestive heart failure
Muito frequente (99-80%)90%
Trombose venosa profundaDeep venous thrombosis
Frequente (79-30%)55%
PalpitaçõesPalpitations
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico3.747PubMed
Últimos 10 anos200publicações
Pico2025108 papers
Linha do tempo
2026Hoje · 2026🧪 2005Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado1
3Fase 32
2Fase 21
·Pré-clínico16
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Hipertensão pulmonar tromboembólica crônica

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

18 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

135 ensaios clínicos encontrados, 20 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥇Melhor nível de evidência: Ensaio randomizado
Timeline de publicações
2.741 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 2.741

#1

A Phase 2, Randomized, Clinical Trial of Inhaled Nitric Oxide for Acute Severe Right Heart Failure With Pulmonary Hypertension (PHiNO Study).

Circulation journal : official journal of the Japanese Circulation Society2026 Mar 21

Acute right heart failure (RHF) is life threatening in patients with pulmonary hypertension (PH). This study investigated the efficacy and safety of inhaled nitric oxide (iNO; INOflo®for inhalation 800 ppm), a rapid pulmonary vasodilator, in patients with acute severe RHF due to PH. In this Phase 2 randomized controlled trial, 30 patients with acute severe RHF due to PH (pulmonary arterial hypertension or chronic thromboembolic PH) were randomized 1 : 1 to either an iNO or control group (which did not receive iNO). The primary endpoint was the change in pulmonary vascular resistance (PVR) from baseline to 30 min after either iNO initiation or patient registration and assignment (control group), which differed significantly between the iNO and control groups (mean [±SD] -2.41±2.47 vs. 0.8±1.03 Wood units, respectively; between group difference -3.21 [95% confidence interval -4.633, -1.785] Wood units). Serum B-type natriuretic peptide (BNP) levels and inferior vena cava diameter (secondary endpoints) decreased significantly in the iNO group over the 7-day study period. No serious adverse events, including methemoglobinemia, were observed. iNO significantly reduced PVR in patients with acute severe RHF due to PH, without serious adverse events. Serum BNP levels and inferior vena cava diameter improved in the iNO group. These findings suggest that iNO is a promising acute treatment option for RHF due to PH.

#2

Prevalence, Clinical Features, and Treatment Response of Chronic Thromboembolic Pulmonary Hypertension in Patients With Myeloproliferative Neoplasm.

Circulation reports2026 Mar 10

Patients with myeloproliferative neoplasms (MPN) are known to complicate pulmonary hypertension (PH). Half of patients with MPN-associated PH have chronic thromboembolic PH (CTEPH); however, the prevalence, clinical characteristics, and treatment response remain unclear. Nagoya PH registry database was retrospectively analyzed. Of 129 CTEPH patients, 82 were included. Clinical characteristics and treatment response were compared between CTEPH patients with MPN (MPN group) and those without MPN (non-MPN group). As the treatment course at Nagoya University Hospital, medical treatment was initiated before performing balloon pulmonary angioplasty (BPA)/pulmonary endarterectomy (PEA). Right heart catheterization was performed at pre-medication, post-medication, and post-BPA/PEA. Seven patients had concomitant MPN as the underlying cause for CTEPH, accounting for 5.4% (7/129) of CTEPH cases. Baseline clinical characteristics were comparable between the MPN and non-MPN groups. No significant difference was observed in ∆pulmonary vascular resistance (PVR) from baseline to post-medical treatment (-3.59 WU in the MPN group vs. -3.80 WU in the non-MPN group; P=0.67) and baseline to post-BPA/PEA (-6.92 WU in the MPN group vs. -7.60 WU in the non-MPN group; P=0.35). As hemodynamic responses to treatment in CTEPH patients with MPN were comparable with those without MPN, their prognosis may improve with multimodal CTEPH treatment similar to non-MPN cases.

#3

Residual physiological abnormalities after pulmonary endarterectomy and balloon pulmonary angioplasty in CTEPH.

PloS one2026

Pulmonary endarterectomy (PEA) is the first-line treatment for chronic thromboembolic pulmonary hypertension (CTEPH), while balloon pulmonary angioplasty (BPA) is an established alternative for inoperable patients. Although both interventions improve resting pulmonary hemodynamics, the extent of long-term physiological recovery during exercise and the persistence of functional limitations remain incompletely characterized. Prospective single-center registry (2017-2023) including 14 patients completing BPA (71 sessions) and 15 undergoing PEA, with median follow-up of 50 months (IQR 36-61). Clinical assessment included resting hemodynamics, invasive exercise right heart catheterization to derive the exercise slope of the mean pulmonary arterial pressure to cardiac output relashionship (mPAP/CO slope), and health-related quality of life (HRQOL) evaluated using the SF-36 questionnaire. Analyses were descriptive and focused on within-pathway changes over time. Both BPA and PEA significantly reduced mPAP (44.8 ± 12.4 → 26.1 ± 9.3 mmHg; 42.1 ± 12.9 → 22.6 ± 5.4 mmHg, both p < 0.001) and pulmonary vascular resistance (9.8 ± 4.6 → 3.0 ± 1.3 WU; 9.0 ± 5.4 → 2.9 ± 1.9 WU, both p < 0.001) at long term follow-up. Despite sustained improvements in resting hemodynamics, abnormal exercise pulmonary vascular responses persisted, with mean mPAP/CO slopes of 7.0 ± 5.6 mmHg/L/min after BPA and 4.0 ± 2.3 mmHg/L/min after PEA. Physical HRQOL remained impaired at long-term follow-up, with Physical Component Summary (PCS) scores below population norms in both pathways (44.4 ± 12.7 after BPA and 44.5 ± 7.3 after PEA). BPA and PEA provide durable improvements in resting pulmonary hemodynamics; however, incomplete physiological recovery is common, with persistent exercise abnormalities and reduced physical quality of life at long-term follow-up.

#4

Clinical Profile and Admission Outcomes of Patients With Acute Pulmonary Embolism at a Resource-Constrained Hospital in Ghana: A Retrospective Pilot Study.

Health science reports2026 Mar

Pulmonary embolism is a cardiovascular disease associated with significant morbidity and mortality. There is a paucity of literature regarding this condition from the Ghanaian perspective. This study aimed at evaluating the clinical profile and admission outcomes of patients with acute pulmonary embolism at the Methodist Hospital, Wenchi, Ghana. A retrospective pilot study was conducted by analyzing medical records of patients diagnosed with acute pulmonary embolism from September 2023 to March 2025. Data on demographics, clinical manifestations, risk factors, investigations, treatment, and outcomes of admission were collected. Out of 17 patients enrolled in the study, 11 (64.7%) were females. The mean age was 58.8 ± 13.0 years. The commonest risk factors were age > 65 years (n = 6), immobilization (n = 5), obesity (n = 4), and recent surgery (n = 3). Hypertension and diabetes mellitus were the predominant comorbidities. Dyspnea (76.5%, n = 13) and chest pain (n = 5) were the most frequent presenting symptoms while tachypnea (70.6%, n = 12), tachycardia (70.6%, n = 12), and hypoxia (52.9%, n = 9) were the commonest clinical signs. Three patients had hemodynamic instability. Pretest probability assessment was infrequently performed (n = 7). Sinus tachycardia (76.5%, n = 13) was the predominant electrocardiographic abnormality. The majority (58.8%, n = 10) had intermediate-risk pulmonary embolism whereas 3 patients were classified as having high-risk pulmonary embolism. Two in-hospital mortalities were recorded. Clinical features and predisposing factors were largely similar to those described in the literature. Also, pretest probability assessment was underutilized. In-hospital mortality rate (11.8%) was relatively high. Large-scale, multicenter prospective studies are recommended to assess long-term complications of acute pulmonary embolism such as recurrence and chronic thromboembolic pulmonary hypertension.

#5

Notch signaling enhances PASMC proliferation and vascular remodeling in CTEPH.

Open life sciences2026 Jan

The Notch signaling pathway is implicated in pulmonary vascular remodeling (PVR) in Chronic Thromboembolic Pulmonary Hypertension (CTEPH). This study investigated the role of Notch signaling in PVR using a rat model of CTEPH and performed measurements including Right Ventricular Systolic Pressure (RVSP), Mean Pulmonary Arterial Pressure (MPAP), and histological analysis of pulmonary small arteries. Western blot analysis revealed elevated levels of Notch1, Notch3, Jagged1, and Hes1 proteins in CTEPH rats. Furthermore, the Notch pathway proteins (Notch1, Notch3, Jagged1, and Hes1) were even more elevated in the CTEPH + VPA group. In contrast, protein levels were reduced in the CTEPH + DAPT (a γ-secretase inhibitor) group. The medial wall thickness percentage (MWT%) and markers of smooth muscle cell proliferation, including PCNA and α-SMA, were significantly increased in the CTEPH and CTEPH + VPA groups and decreased after DAPT treatment. These findings suggest that activation of the Notch signaling pathway promotes the proliferation of Pulmonary Artery Smooth Muscle Cells (PASMCs), contributing to PVR in CTEPH. Inhibition of Notch signaling with DAPT mitigated vascular remodeling, suggesting a potential therapeutic target for CTEPH.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC2.276 artigos no totalmostrando 196

2026

Long term effects of medical therapy pre- and post- pulmonary endarterectomy - insights from the UK CURATE registry.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2026

A Phase 2, Randomized, Clinical Trial of Inhaled Nitric Oxide for Acute Severe Right Heart Failure With Pulmonary Hypertension (PHiNO Study).

Circulation journal : official journal of the Japanese Circulation Society
2026

Carbon dioxide angiography-guided balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension with iodinated contrast allergy.

Cardiovascular intervention and therapeutics
2026

[Sleep disorders dynamics in patients with chronic thromboembolic pulmonary hypertension after surgical treatment].

Terapevticheskii arkhiv
2026

Surgical thrombus removal in acute pulmonary embolism. Where do we stand today?

The Journal of cardiovascular surgery
2026

Cone-Beam Computed Tomography Scan and Three-Dimensional Roadmap for Balloon Pulmonary Angioplasty.

The Kurume medical journal
2026

Provider networks for pulmonary hypertension in Massachusetts: implications for improving referrals to expert care.

Annals of the American Thoracic Society
2026

Critical Care Management of the Patient with Pulmonary Hypertension.

Journal of intensive care medicine
2026

Exercise for treatment and prevention of post-pulmonary embolism syndrome: A review.

Vascular medicine (London, England)
2026

Deep learning-based identification of chronic pulmonary embolism on CTPA: a regional lung analysis using multiplanar MIP images.

European radiology experimental
2026

Animal models of chronic thromboembolic pulmonary hypertension.

Animal models and experimental medicine
2026

Exercise testing in chronic thromboembolic pulmonary hypertension and chronic thromboembolic pulmonary disease without pulmonary hypertension: a comprehensive systematic review and meta-analysis.

European journal of internal medicine
2026

Respond to "comments and opinions regarding "High antiphospholipid antibody titers and outcomes of pulmonary endarterectomy: a single-center retrospective observational cohort study" by Miard et al.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2026

[Use of modified balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension: a retrospective study from a single center].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2026

Application of murine hindlimb deep vein thrombosis model to assess temporal evolution and hemodynamic sequelae of pulmonary embolism.

Biochemical and biophysical research communications
2026

Chronic thromboembolic pulmonary hypertension: insights from the 100 most cited papers: a bibliometric perspective.

Journal of thoracic disease
2026

Role of PKM2 Tetramer in Modulating Endothelial Mitochondrial Dysfunction in a Rat Model of Chronic Thromboembolic Pulmonary Hypertension.

Physiological research
2026

Perioperative Use of Pulmonary Artery Catheter in a Patient With Severe Chronic Thromboembolic Pulmonary Hypertension Undergoing Major Gynecological Surgery: A Case Report.

Cureus
2026

Prevalence, Clinical Features, and Treatment Response of Chronic Thromboembolic Pulmonary Hypertension in Patients With Myeloproliferative Neoplasm.

Circulation reports
2026

Smoking exposure on diagnosis and survival of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Data from REHAP registry.

Pulmonology
2026

Residual physiological abnormalities after pulmonary endarterectomy and balloon pulmonary angioplasty in CTEPH.

PloS one
2026

Clinical Profile and Admission Outcomes of Patients With Acute Pulmonary Embolism at a Resource-Constrained Hospital in Ghana: A Retrospective Pilot Study.

Health science reports
2025

Distinct endothelial cells in chronic thromboembolic pulmonary hypertension.

NPJ cardiovascular health
2026

In vivo targeting of fibroblast activation in chronic thromboembolic pulmonary hypertension: Ready for pulmonary prime time?

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
2026

Notch signaling enhances PASMC proliferation and vascular remodeling in CTEPH.

Open life sciences
2026

Post-pulmonary embolism syndrome: a practical narrative review.

Revista clinica espanola
2026

[Rehabilitation after pulmonary Embolism].

Die Rehabilitation
2026

2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Journal of the American College of Cardiology
2026

Performance of Guideline-Recommended Approaches to Echocardiographic Investigation for Pulmonary Hypertension: Analysis of the CIPHER Study.

Pulmonary circulation
2026

Current perspectives on imaging modalities in the diagnosis and management of pulmonary hypertension.

Respiratory investigation
2026

A diagnostic challenge: unveiling chronic thromboembolic pulmonary hypertension in the absence of visible thrombi: a case report.

European heart journal. Case reports
2026

Diagnostic Performance of Quantitative Lung Perfusion SPECT/CT for Chronic Thromboembolic Pulmonary Hypertension: A Pilot Study.

Diagnostics (Basel, Switzerland)
2026

Pulmonary thromboendarterectomy and cavotomy of calcified superior vena cava.

Turk gogus kalp damar cerrahisi dergisi
2026

Echocardiographic Assessment After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension: Which Parameters Reflect Improved Right Ventricular Function?

Pulmonary circulation
2026

Chronic Thromboembolic Pulmonary Hypertension and Elevated Pulmonary Arterial Wedge Pressure: No Fear of BPA!

Chest
2026

Right Atrial Function and Tricuspid Regurgitation in Chronic Thromboembolic Pulmonary Hypertension.

Echocardiography (Mount Kisco, N.Y.)
2026

Expanding the boundaries of PTE: successful integration with multiple major cardiac procedures.

Journal of surgical case reports
2026

Obstructive sleep apnea and echocardiographic indicators of elevated pulmonary hypertension probability after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.

Sleep medicine
2026

Temporal Trends in Age Profile and Safety of Balloon Pulmonary Angioplasty for CTEPH.

JACC. Asia
2026

Impact of Preoperative Hemodynamic Values on Development of Reperfusion Edema After Pulmonary Endarterectomy.

Pulmonary circulation
2026

Vascular Obstruction Scoring on Dual-energy CT, Cone-beam CT and Digital Subtraction Angiography: Correlation with Invasive Hemodynamics in Chronic Thromboembolic Pulmonary Hypertension.

Academic radiology
2026

microRNAs as epigenetic biomarkers for CTEPH: a case-control study towards personalised medicine.

ERJ open research
2026

How long does chronic thromboembolic pulmonary hypertension take to develop? Two cases of post-thrombotic complete occlusion of the left pulmonary artery.

Polish archives of internal medicine
2026

Transmembrane Protein 100 Expression on Endothelial Cells Vascularizing Thrombi in Chronic Thromboembolic Pulmonary Hypertension Modulates TGFβ1-ALK1 Signaling During Angiogenesis.

Pulmonary circulation
2025

A swine model of severe chronic thromboembolic pulmonary hypertension induced by repeated pulmonary artery long suture injection.

Frontiers in cardiovascular medicine
2026

Stress Echocardiography to Detect Exercise Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Disease.

Pulmonary medicine
2026

Pulmonary endarterectomy in antiphospholipid syndrome: a retrospective analysis from the Saudi pulmonary hypertension registry.

Frontiers in medicine
2026

Role and interpretation of lung scintigraphy for long-term management of pulmonary embolism.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
2025

Efficacy and safety of specific treatment combined with SGLT2-i in pulmonary hypertension.

Frontiers in cardiovascular medicine
2025

Effects of balloon pulmonary angioplasty on cardiac and pulmonary functions and complications in patients with chronic thromboembolic pulmonary hypertension.

Frontiers in medicine
2026

Post-Pulmonary Embolism Syndrome: New Phenotypes Come into Focus.

Journal of clinical medicine
2026

Pulmonary Embolism in Antiphospholipid Syndrome (APS)-Where Are We and Where Are We Going?

International journal of molecular sciences
2026

Genetic and Clinical Determinants of Chronic Thromboembolic Pulmonary Hypertension: The Role of PAI-1 Polymorphism.

International journal of molecular sciences
2026

Perfusion-only Q-SPECT as a rule-out tool for CTEPH in resource-limited settings: a feasibility study on reducing unnecessary referrals to tertiary centers.

BMC pulmonary medicine
2026

Exercise tolerance in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty.

Heart &amp; lung : the journal of critical care
2026

sST2 and IL-6 predict prognosis of medically treated chronic thromboembolic pulmonary hypertension.

The European respiratory journal
2026

Development and Characterization of a Novel Chronic Thromboembolic Pulmonary Hypertension Rat Model: Identifying Sell-Podxl as Potential Regulators.

Hypertension (Dallas, Tex. : 1979)
2026

Stress testing in the diagnosis and early screening of chronic thromboembolic pulmonary disease with and without pulmonary hypertension.

European journal of clinical investigation
2026

Role of hsa-miR-122-5p in chronic thromboembolic pulmonary hypertension and chronic thromboembolic disease: Targeting PIK3CG in the PI3K/Akt signaling pathway.

Medicine
2026

Management of airway hemorrhage with endobronchial valve in patients undergoing pulmonary endarterectomy- an expert center experience: a case report.

BMC anesthesiology
2026

Anticoagulation in chronic thromboembolic pulmonary hypertension: an updated systematic review and meta-analysis.

Internal and emergency medicine
2026

Artificial intelligence in lung scintigraphy.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
2026

Prognostic Value of Acute Vasoreactivity in Chronic Thromboembolic Pulmonary Hypertension.

Pulmonary circulation
2026

Lung transplantation for chronic thromboembolic pulmonary hypertension.

JHLT open
2026

Preoperative Right Ventricle-to-Pulmonary Artery Coupling Correlates With Intensive Care Length of Stay After Pulmonary Endarterectomy.

Journal of cardiothoracic and vascular anesthesia
2026

Pulmonary Venous Atresia as a Mimicker of Chronic Thromboembolic Pulmonary Disease: Diagnostic Utility of Ventilation/Perfusion Scanning.

Journal of nuclear medicine technology
2026

What is the difference between pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension on phase-resolved functional lung MRI? A cross-sectional observational study.

European radiology
2026

Echocardiographic Analysis of Tricuspid Regurgitation and Other Hemodynamic Factors in Relation to Right Atrial Function in Patients With Chronic Thromboembolic Pulmonary Hypertension.

Echocardiography (Mount Kisco, N.Y.)
2025

Chronic Thromboembolic Pulmonary Hypertension Incidence, Post-pulmonary Embolism Syndrome and Possible Role of Transcatheter Therapy in Prevention.

Interventional cardiology (London, England)
2025

Current Perspectives on Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.

Journal of clinical medicine
2025

Clarifying the Clinical Utility of NTAR/RGR for PAH and CTEPH. Comment on Iancu et al. Evaluating NT-proBNP-to-Albumin (NTAR) and RDW-to-eGFR (RGR) Ratios as Biomarkers for Predicting Hospitalization Duration and Mortality in Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH). Diagnostics 2025, 15, 2126.

Diagnostics (Basel, Switzerland)
2025

Lung Tissue RNA Sequencing Shows Dysregulation of the Bronchial Epithelium in a Rat Model of Chronic Thromboembolic Pulmonary Hypertension.

Bulletin of experimental biology and medicine
2026

Is Septic Revision Knee Arthroplasty Associated with Higher Thromboembolic Events? A Matched Cohort Study.

The Journal of arthroplasty
2026

Pulmonary tumour thrombotic microangiopathy or chronic thromboembolic pulmonary hypertension?-diagnosed by pulmonary wedge aspiration cytology using a Swan-Ganz catheter: a case report.

European heart journal. Case reports
2026

Significance of diffusing capacity of the lungs for carbon monoxide on chronic thromboembolic pulmonary hypertension.

Thorax
2026

Management of Chronic Thromboembolic Pulmonary Hypertension Before and After Pulmonary Thromboendarterectomy.

Chest
2026

[Balloon pulmonary angioplasty in Gottsegen National Cardiovascular Center - results of the first 2 years].

Orvosi hetilap
2026

Haemodynamic and clinical impacts of switching phosphodiesterase-5 inhibitors to riociguat in patients with chronic thromboembolic pulmonary hypertension (CTEPH) after balloon pulmonary angioplasty (BPA) - a prospective cohort study.

BMC pulmonary medicine
2025

Severe pulmonary hypertension associated with unilateral pulmonary artery hypoplasia: A case report.

ARYA atherosclerosis
2026

Splenectomy Increases CTEPH Risk and Modifies Clinical Features of Acute Pulmonary Embolism.

Pulmonary circulation
2025

Optimizing surgical management for pulmonary artery sarcoma: A 24-year single-center analysis.

JTCVS open
2025

Leveraging Vascular Over Ventricular Ratios in Observational Chronic Thromboembolic Pulmonary Hypertension and Acute Pulmonary Embolism Cohorts to Decode Clot Chronicity on Computed Tomography Angiography.

Pulmonary circulation
2025

Evaluation of Predisposing Factors and Coexisting Diseases in the Development of Chronic Thromboembolic Pulmonary Disease.

The clinical respiratory journal
2025

Elevated tricuspid peak systolic gradient with enlarged right ventricle present during acute episode of pulmonary embolism predict subsequent chronic thromboembolic pulmonary hypertension.

Thrombosis journal
2026

Large-bore mechanical thrombectomy vs standard of care for acute high-risk pulmonary embolism: Rationale and design of the PERSEVERE randomized controlled trial.

American heart journal
2025

Follow-up algorithm for detecting chronic sequelae of pulmonary embolism: diagnostic performance and possible limitations.

Journal of thrombosis and haemostasis : JTH
2025

Diagnostic performance of lung perfusion SPECT/CT using perfusion defect and decrease criteria: a comparative study with CTPA in pulmonary thromboembolism.

Annals of nuclear medicine
2025

Minimally Invasive Pulmonary Thromboendarterectomy by a J-Shaped Upper Hemisternotomy.

Annals of thoracic surgery short reports
2025

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Patient Selection, Procedural Pearls, and Expected Outcomes.

Seminars in interventional radiology
2025

Screening for an underlying myeloproliferative neoplasm in patients with chronic thromboembolic pulmonary hypertension.

Respiratory medicine and research
2026

Real-World Treatment Patterns and Burden of Chronic Thromboembolic Pulmonary Hypertension Patients across Consultation Settings in the USA.

Pulmonary therapy
2025

Pulmonary hemorrhage after pulmonary endarterectomy in a patient with chronic thromboembolic pulmonary hypertension: a case report.

The journal of extra-corporeal technology
2025

Combining pulmonary endarterectomy and balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a narrative review of hybrid therapy approaches.

ERJ open research
2026

[Analysis of follow-up and prognosis in pediatric rheumatic diseases associated with pulmonary embolism].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2025

From Patient-Specific Hemodynamic Modeling to Clinical Decision-Making in Chronic Thromboembolic Pulmonary Hypertension: Opportunities and Caveats.

Pulmonary circulation
2025

From Deep Hypothermia to Goal-Directed Perfusion: Contemporary Insights Into Perfusion Techniques for Pulmonary Endarterectomy, Including a Narrative Review and Perspectives.

Cureus
2025

Cerebral, Muscle and Blood Oxygenation in Patients with Pulmonary Vascular Disease Whilst Breathing Normobaric Hypoxia vs. Normoxia Before and After Sildenafil: Data from a Randomised Controlled Trial.

Journal of clinical medicine
2025

Sclerotherapy embolism: a novel etiology for chronic thromboembolic pulmonary disease.

BMC pulmonary medicine
2025

Overexpression of PRDX2 alleviates chronic thromboembolic pulmonary hypertension by modulating inflammation and mitophagy.

Scientific reports
2025

Upfront combination therapy with sildenafil and ambrisentan in patients with chronic thromboembolic pulmonary hypertension.

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
2025

Survival in patients with chronic thromboembolic pulmonary hypertension treated with riociguat versus other medications: a COMPERA analysis.

ERJ open research
2025

Long-term effects of medical treatment in patients with chronic thromboembolic pulmonary hypertension.

ERJ open research
2025

Association of bioelectrical impedance phase angle with exercise tolerance in patients with chronic thromboembolic pulmonary hypertension.

Scientific reports
2025

8 F Catheter Percutaneous Mechanical Thrombectomy Plus Anticoagulation Versus Anticoagulation Alone in Intermediate-High Risk Acute Pulmonary Embolism: A Multicenter Real-World Study on Long-Term Complications, Right Heart Function, and Quality of Life.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography &amp; Interventions
2025

[Venous thromboembolism : therapeutic strategies].

Revue medicale suisse
2025

SPHK1-mediated M2 macrophage polarization drives TGF-β1-dependent thrombus fibrosis.

Frontiers in immunology
2025

Impact of Stress Hyperglycemia Ratio on Adverse Outcomes in Patients With Chronic Thromboembolic Pulmonary Hypertension.

Clinical and translational science
2026

Old clots, new questions - the anticoagulation saga continues in chronic thromboembolic pulmonary hypertension.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2025

[Chronic thromboembolic pulmonary hypertension - the hidden disease].

Orvosi hetilap
2025

Application and Challenges of Deep Learning in Pulmonary Vessels Segmentation of CTPA Images.

IEEE journal of biomedical and health informatics
2025

Efficacy of balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension in patients with cancer comorbidity.

Kardiologia polska
2026

Comparative outcomes of ultrasound-assisted catheter-directed thrombolysis between patients with acute and acute-on-chronic pulmonary embolism.

Thrombosis research
2025

Why Is Pulmonary Endarterectomy Underused in Japan? Epidemiology, Genetics, and a Practical Operability Framework.

Pulmonary circulation
2025

Inflammation-Based Hematologic Indices as Prognostic Markers in Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension: A Hypothesis-Generating Registry Study.

International journal of molecular sciences
2025

Genetic Analysis of Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Single-Center Observational Study.

Genes
2026

Results of the MACiTEPH study of macitentan for the treatment of inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2026

Dual-energy computed tomography (CT) versus cone-beam computed tomography (CT) in chronic thromboembolic pulmonary hypertension: diagnostic accuracy compared with digital subtraction angiography.

Clinical radiology
2025

Enhancing methodological rigour in meta-analyses of renal dysfunction and outcomes in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

The European respiratory journal
2026

Quantifying right ventricular fibrosis burden in chronic thromboembolic pulmonary hypertension via fibroblast activation protein inhibitor single photon emission computed tomography/computed tomography: Correlation with echocardiographic parameters and balloon pulmonary angiography response.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
2025

The relationship between preoperative clinical, respiratory, and hemodynamic parameters and the surgical anatomical classification of thrombi in patients with chronic thromboembolic pulmonary hypertension.

BMC pulmonary medicine
2025

Cardiovascular MRI-based Biventricular Perfusion Assessment in Two Patients with Chronic Thromboembolic Pulmonary Hypertension Undergoing Pulmonary Thromboendarterectomy.

Radiology. Cardiothoracic imaging
2025

A scoping review of photon-counting detector computed tomography in cardiovascular imaging.

Diagnostic and interventional radiology (Ankara, Turkey)
2025

Circulating Pin1 Levels in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Case-Control Study.

Pulmonary circulation
2025

Catheter-directed versus standard therapy in intermediate-high-risk pulmonary embolism: A retrospective cohort study.

Archives of cardiovascular diseases
2025

American Lung Association Pulmonary Hypertension Roundtable: Executive Summary.

Pulmonary circulation
2025

Proximal pulmonary artery wall shear stress derived from computational fluid dynamics: A noninvasive biomarker for CTEPH and perfusion mismatch.

Physiological reports
2026

In situ pulmonary arterial thrombosis in pulmonary arterial hypertension: Diagnostic differentiation, imaging criteria, and management-A narrative review with an institutional case-series snapshot.

Current problems in cardiology
2026

Pulmonary artery fresh floating thrombus in patients with chronic thromboembolic pulmonary hypertension on low-dose direct oral anticoagulants: A single-center angiographic observational study.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2025

Characteristics of ferritinophagy-related genes in chronic thromboembolic pulmonary hypertension, a study based on bioinformatics with machine learning model.

Respiratory medicine
2025

Magnetic resonance direct thrombus imaging to distinguish acute pulmonary embolism from chronic thromboembolic pulmonary hypertension: a case report.

European heart journal. Case reports
2025

The activin pathway in chronic thromboembolic pulmonary hypertension: a potential biomarker for residual pulmonary hypertension after endarterectomy.

ERJ open research
2025

From Pathways to Patients: Contemporary Approaches to Pulmonary Hypertension.

Cardiology in review
2025

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: A Nationwide Prospective Multicenter Registry in Japan (J-BPA).

Circulation. Cardiovascular interventions
2025

Chronic thromboembolic pulmonary hypertension associated with venous thoracic outlet syndrome: a retrospective case series.

The European respiratory journal
2025

Increased lung [18F]-FDG uptake in chronic thromboembolic pulmonary hypertension with distal involvement.

The European respiratory journal
2025

The Predictive Value of Quantitative Analysis of SPECT V/Q Imaging for Postoperative Persistent/Recurrent Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy.

Pulmonary circulation
2025

Emergency Pulmonary Thromboendarterectomy in Malignancy.

JACC. Case reports
2025

Causal Effect of Pulmonary Hypertension on Brain Structure: A Mendelian Randomization Study Combined With Brain Magnetic Resonance Imaging.

Cureus
2025

The expanding role of intraoperative transesophageal echocardiography in pulmonary endarterectomy for CTEPH.

Indian journal of thoracic and cardiovascular surgery
2025

Bridging to a delayed pulmonary endarterectomy in massive acute-on-chronic pulmonary thromboembolism: a case report.

Journal of cardiothoracic surgery
2025

A Tale of Two Pathologies: Unraveling CTEPH and PVOD in Pulmonary Hypertension.

American journal of respiratory and critical care medicine
2025

Diagnosis model for assessing chronic thromboembolic pulmonary hypertension in high-altitude pulmonary embolism patients: a machine learning approach.

Frontiers in medicine
2025

Factors affecting patient outcomes in pulmonary artery thromboendarterectomy under deep hypothermic circulatory arrest and cardiopulmonary bypass support----a single center's experience.

BMC cardiovascular disorders
2025

Pulmonary Blood Volumes on CT Predict Residual Pulmonary Hypertension Post-Pulmonary Endarterectomy.

American journal of respiratory cell and molecular biology
2026

Impact of Elevated Pulmonary Arterial Wedge Pressure on Safety and Efficacy of Balloon Pulmonary Angioplasty in the Treatment of Chronic Thromboembolic Pulmonary Hypertension.

Chest
2025

Intravenous Treprostinil in Precapillary and Postcapillary Pulmonary Hypertension Due to Cardiac Amyloidosis and Aortic Stenosis.

JACC. Case reports
2026

Lung transplantation for chronic thromboembolic pulmonary hypertension (CTEPH): A treatment of last resort.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2025

Patient-Specific Haemodynamic Modeling to Estimate the Extent of Microvascular Disease and Response to Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension.

Pulmonary circulation
2025

The Surgical Management of Chronic Thromboembolic Pulmonary Hypertension.

Journal of clinical medicine
2025

Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension after bilateral lung transplantation.

JHLT open
2025

Proteomic insights into platelet dysregulation and pathogenic mechanisms of chronic thromboembolic pulmonary hypertension.

Journal of translational medicine
2025

Evaluation of gene and microRNA expression patterns in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension as rare diseases.

Respiratory medicine
2026

Lung transplantation for chronic thromboembolic pulmonary hypertension-a case series.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2025

An Unusual Initial Manifestation of Pulmonary Embolism: Aseptic Cavitary Infarction With Pulmonary Hypertension-Case Report and Literature Review.

Respirology case reports
2025

Quantitative Evaluation of Lung Perfusion by Dynamic Chest Radiography in Chronic Thromboembolic Pulmonary Hypertension: Comparison With Lung Perfusion Scintigraphy.

Pulmonary circulation
2025

[Chronic Thromboembolic Pulmonary Hypertension].

Pneumologie (Stuttgart, Germany)
2025

[Innovations in the Field of Pulmonary Hypertension - Critical Assessment of the Results of the 7th World Symposium on Pulmonary Hypertension].

Pneumologie (Stuttgart, Germany)
2025

Use of direct anticoagulants in chronic thromboembolic pulmonary hypertension: An anatomopathological study of endarterectomy material.

International journal of cardiology
2025

The influence factors on the resolution of pulmonary embolism by CT pulmonary angiography.

Thrombosis journal
2025

Balloon Pulmonary Angioplasty Versus Riociguat in Inoperable Chronic Thromboembolic Pulmonary Hypertension: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Cardiology in review
2025

Long-Term Outcomes of Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis.

Journal of the Society for Cardiovascular Angiography &amp; Interventions
2026

Endothelin-1 overexpression in pulmonary endarterectomy specimens of CTEPH patients is associated with pulmonary hypertension development.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2025

Tricuspid Regurgitation and Pulmonary Haemodynamics After Pulmonary Endarterectomy.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
2025

Congenital Thrombophilia in Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Systematic Review of Prevalence, Clinical Phenotype, and Surgical Outcomes.

Biomedicines
2025

A machine learning approach to identify patients at risk for long-term consequences after pulmonary embolism.

Scientific reports
2025

Practical guide to management after an acute pulmonary embolism.

BMJ open respiratory research
2025

Imaging in chronic thromboembolic pulmonary hypertension: review of the current literature.

Diagnostic and interventional radiology (Ankara, Turkey)
2026

Gas exchange dynamics and responses to exercise in chronic thromboembolic pulmonary hypertension.

Respiratory physiology &amp; neurobiology
2025

Effectiveness and Safety of Reduced-Dose and Slow-Infusion Intravenous Tissue-Type Plasminogen Activator Regimen in Patients with Acute Pulmonary Embolism at Intermediate-High Risk.

Anatolian journal of cardiology
2025

A Rare Case of Chronic Thromboembolic Pulmonary Hypertension in an Elderly With Atrial Septal Defect and Eisenmenger Syndrome.

Cureus
2025

Long-term in-hospital mortality and chronic thromboembolic pulmonary hypertension after COVID-19-associated pulmonary embolism in France: a nationwide study.

ERJ open research
2025

Effects of Web-Based Symptom Monitoring Program on Symptom Interference, Physical Activity, and Emergency Department Readmissions in Patients With Pre-Capillary Pulmonary Hypertension: Randomized Controlled Trial.

Journal of medical Internet research
2025

Pulmonary thrombectomy and extracorporeal membrane oxygenation: a case study.

The journal of extra-corporeal technology
2025

Evaluating NT-proBNP-to-Albumin (NTAR) and RDW-to-eGFR (RGR) Ratios as Biomarkers for Predicting Hospitalization Duration and Mortality in Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH).

Diagnostics (Basel, Switzerland)
2025

Riociguat for CTEPH: A retrospective cohort study from a single reference center in Brazil.

Clinics (Sao Paulo, Brazil)
2025

Spatial heterogeneity and distribution of CT-Based pulmonary vascular volumes in chronic thromboembolic pulmonary hypertension.

European journal of radiology
2025

Clinical impact of mean pulmonary arterial pressure after balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension.

Open heart
2026

CT scoring system to defined thrombus distribution in chronic thromboembolic pulmonary hypertension.

The British journal of radiology
2025

Chronic Thromboembolic Pulmonary Hypertension in Latvia: Epidemiological Insights and Diagnostic Challenges From 2024.

Pulmonary circulation
2025

High Antiphospholipid Antibody Titers and Outcomes of Pulmonary Endarterectomy: A Single-Center Retrospective Observational Cohort Study.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2025

Renal Outcomes After Lung or Combined Heart-Lung Transplantation in Pulmonary Hypertension.

Pulmonary circulation
2025

Sequential Combination of Balloon Pulmonary Angioplasty for Distal Lesions in the Left Pulmonary Artery Followed by Pulmonary Endarterectomy for Central Lesions in the Right Pulmonary Artery: A Case Report.

Pulmonary circulation
2025

Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: Technical challenges and controversies.

JHLT open
2026

Klippel-Trenaunay Syndrome with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty.

Pneumologie (Stuttgart, Germany)
2025

Assessment of Right Ventricular Pressure in Chronic Thromboembolic Pulmonary Hypertension: Comparison of Diagnostic Modalities and Balloon Pulmonary Angioplasty Outcomes.

Diagnostics (Basel, Switzerland)
2025

The Effect of Eccentric Cycling on Cerebral and Muscle Tissue Oxygenation in Patients with Pulmonary Hypertension and Healthy Individuals: A Randomized Controlled Crossover Trial.

Journal of clinical medicine
2025

Echo-Doppler Predictors of Residual Pulmonary Hypertension After Pulmonary Thromboendarterectomy.

Journal of clinical medicine
2025

Impact of the Balloon Pulmonary Angioplasty on the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension: From the COMMAND VTE Registry-2.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography &amp; Interventions
2026

Utility of machine learning for predicting severe chronic thromboembolic pulmonary hypertension based on CT metrics in a surgical cohort.

European radiology
2026

Combined multimodal therapy in high-risk patients with chronic thromboembolic pulmonary hypertension and both distal and proximal lesions: A prospective observational cohort study.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
2025

Hemodynamics assessment using 4D flow CMR before and after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a retrospective observational study.

BMC cardiovascular disorders
2025

Detectability of subsegmental lesions in patients with inoperable CTEPH: Comparison between ultra-high-resolution vs. conventional CT.

JHLT open
2025

Pathogenesis, Diagnosis, and Management of Chronic Thromboembolic Pulmonary Hypertension.

Cardiac electrophysiology clinics
2025

Management of Complications of Balloon Pulmonary Angioplasty.

Cardiac electrophysiology clinics
2025

Outpatient Follow-up of Pulmonary Embolism: Putting It all Together.

Cardiac electrophysiology clinics
2025

Evolving Role and Clinical Evidence in the Global Practice of Balloon Pulmonary Angioplasty.

Cardiac electrophysiology clinics
Ver todos os 2.276 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Hipertensão pulmonar tromboembólica crônica.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Hipertensão pulmonar tromboembólica crônica

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. A Phase 2, Randomized, Clinical Trial of Inhaled Nitric Oxide for Acute Severe Right Heart Failure With Pulmonary Hypertension (PHiNO Study).
    Circulation journal : official journal of the Japanese Circulation Society· 2026· PMID 41866186mais citado
  2. Prevalence, Clinical Features, and Treatment Response of Chronic Thromboembolic Pulmonary Hypertension in Patients With Myeloproliferative Neoplasm.
    Circulation reports· 2026· PMID 41808951mais citado
  3. Residual physiological abnormalities after pulmonary endarterectomy and balloon pulmonary angioplasty in CTEPH.
    PloS one· 2026· PMID 41790757mais citado
  4. Clinical Profile and Admission Outcomes of Patients With Acute Pulmonary Embolism at a Resource-Constrained Hospital in Ghana: A Retrospective Pilot Study.
    Health science reports· 2026· PMID 41782653mais citado
  5. Notch signaling enhances PASMC proliferation and vascular remodeling in CTEPH.
    Open life sciences· 2026· PMID 41767099mais citado
  6. Serious respiratory distress associated with bosentan administration in chronic thromboembolic pulmonary hypertension: A case report.
    Therapie· 2026· PMID 41991455recente
  7. Optimization of pulmonary blood flow analysis method using dynamic chest radiography.
    J Appl Clin Med Phys· 2026· PMID 41987020recente
  8. Biological Sex Differences in the US-CTEPH-R.
    Ann Am Thorac Soc· 2026· PMID 41981721recente
  9. Understanding the Impact of Hypoxia on Pulmonary Artery Endothelial Cells in Chronic Thromboembolic Pulmonary Hypertension Patients.
    Int J Mol Sci· 2026· PMID 41977391recente
  10. Automated attenuation analysis of CT pulmonary angiography identifies peripheral hyperperfusion as a prognostic marker in non-surgical chronic thromboembolic pulmonary hypertension (CTEPH).
    Quant Imaging Med Surg· 2026· PMID 41972078recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:70591(Orphanet)
  2. OMIM OMIM:612862(OMIM)
  3. MONDO:0013024(MONDO)
  4. GARD:13124(GARD (NIH))
  5. Busca completa no PubMed(PubMed)
  6. Q1958249(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Hipertensão pulmonar tromboembólica crônica
Compêndio · Raras BR

Hipertensão pulmonar tromboembólica crônica

ORPHA:70591 · MONDO:0013024
Prevalência
Unknown
Herança
Not applicable
CID-10
I26.0 · Embolia pulmonar com menção de cor pulmonale agudo
CID-11
Ensaios
20 ativos
Início
Adolescent, Adult, Elderly
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C2363973
Repurposing
141 candidatos
acebutololadrenergic receptor antagonist
alaceprilangiotensin converting enzyme inhibitor
aliskiren-hemifumaraterenin inhibitor
+17 outros
EuropePMC
Wikidata
Papers 10a
Evidência
🥇 Ensaio rand.
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades